Osteopontin expression in lung cancer
- 30 November 1996
- journal article
- research article
- Published by Elsevier in Lung Cancer
- Vol. 15 (3), 311-323
- https://doi.org/10.1016/0169-5002(95)00595-1
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Molecular events in lung cancerLung Cancer, 1995
- Lung cancerCancer, 1995
- Identification of a ras-Activated Enhancer in the Mouse Osteopontin Promoter and Its Interaction with a Putative ETS-Related Transcription Factor Whose Activity Correlates with the Metastatic Potential of the CellMolecular and Cellular Biology, 1995
- Overcoming obstacles to metastasis ‐ defenses against host defenses: Osteopontin (OPN) as a shield against attack by cytotoxic host cellsJournal of Cellular Biochemistry, 1994
- The Molecular Biology of Lung Cancer PathogenesisChest, 1993
- Cancer statistics, 1993CA: A Cancer Journal for Clinicians, 1993
- Molecular markers for the diagnosis and prognosis of lung cancerCancer, 1992
- Secreted phosphoprotein mrna is induced during multi‐stage carcinogenesis in mouse skin and correlates with the metastatic potential of murine fibroblastsInternational Journal of Cancer, 1990
- The Nature and Significance of OsteopontinConnective Tissue Research, 1989
- Identification of the major phosphoprotein secreted by many rodent cell lines as 2AR/osteopontin: Enhanced expression in H-RAS-transformed 3T3 cellsBiochemical and Biophysical Research Communications, 1988